DADC
AVXL icon

D.A. Davidson & Co’s Anavex Life Sciences AVXL Stock Holding History

D.A. Davidson & Co’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,335
Closed -$88.7K – 1449
2025
Q1 		$88.7K Sell
10,335
-1,050
-9% -$9.91K ﹤0.01% 1369
2024
Q4 		$122K Buy
+11,385
New +$87.6K ﹤0.01% 1371
2024
Q2 		– Sell
-13,770
Closed -$70.1K – 1372
2024
Q1 		$70.1K Buy
13,770
+2,520
+22% +$14.2K ﹤0.01% 1352
2023
Q4 		$105K Buy
+11,250
New +$77.4K ﹤0.01% 1321

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $1.74B AUM 32.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return